Journal of Experimental & Clinical Cancer Research (Sep 2024)

MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5

  • Da Wang,
  • Junsheng Chen,
  • Guanhua Wu,
  • Fei Xiong,
  • Wenzheng Liu,
  • Qi Wang,
  • Yiyang Kuai,
  • Wenhua Huang,
  • Yongqiang Qi,
  • Bing Wang,
  • Ruizhi He,
  • Yongjun Chen

DOI
https://doi.org/10.1186/s13046-024-03188-4
Journal volume & issue
Vol. 43, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Background Cholangiocarcinoma (CCA) is a highly malignant, rapidly progressing tumor of the bile duct. Owing to its chemoresistance, it always has an extremely poor prognosis. Therefore, detailed elucidation of the mechanisms of chemoresistance and identification of therapeutic targets are still needed. Methods We analyzed the expression of MBD2 (Methyl-CpG-binding domain 2) in CCA and normal bile duct tissues using the public database and immunohistochemistry (IHC). The roles of MBD2 in CCA cell proliferation, migration, and chemoresistance ability were validated through CCK-8, plate cloning assay, wound healing assays and xenograft mouse model. In addition, we constructed a primary CCA mouse model to further confirm the effect of MBD2. RNA-seq and co-IP-MS were used to identify the mechanisms by how MBD2 leads to chemoresistance. Results MBD2 was upregulated in CCA. It promoted the proliferation, migration and chemoresistance of CCA cells. Mechanistically, MBD2 directly interacted with WDR5, bound to the promoter of ABCB1, promoted the trimethylation of H3K4 in this region through KMT2A, and activated the expression of ABCB1. Knocking down WDR5 or KMT2A blocked the transcriptional activation of ABCB1 by MBD2. The molecular inhibitor MM-102 targeted the interaction of WDR5 with KMT2A. MM-102 inhibited the expression of ABCB1 in CCA cells and decreased the chemoresistance of CCA to cisplatin. Conclusion MBD2 promotes the progression and chemoresistance of CCA through interactions with WDR5. MM-102 can effectively block this process and increase the sensitivity of CCA to cisplatin.

Keywords